This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Juvenile chronic arthritis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Juvenile idiopathic arthritis (formerly juvenile chronic arthritis in Europe and juvenile rheumatoid arthritis in North America) is an umbrella term used to describe a heterogeneous group of several disease subtypes occurring in someone who is less than 16 years old that lasts for more than six weeks and are of unknown cause (1).

  • it is the most common rheumatologic condition of childhood
  • consists of subtypes which includes -
    • oligoarticular - affecting 1-4 joints
    • polyarticular - 5 or more joints are affected
    • systemic onset (1,2)

The aetiology of this condition is thought to be multifactorial with both environmental and genetic factors playing key roles

  • most common risk factors are infections in combination with genetic susceptibility. In addition stress and maternal smoking have also been reported to be involved in the pathogenesis
  • multiple genes have been shown to be associated with the aetiology of JIA .
    • human leukocyte antigen (HLA) B27 and the other HLA tissue types are the most common genes involved (1,3)

Note that the term Still's disese, which has in the past been used generically in this condition, is now taken to imply systemic onset juvenile chronic arthritis.

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.